Week Ahead – The final stretch
The great debate on value investing
CTAs Are Approaching A Liquidation Trigger Point As They Sell Treasuries
Italy Reports Record Jump In COVID-19 Cases; New Jersey Sees Surge In ICU Occupancy: Live Updates
Short Lines Greet Latest iPhone Release In China
America: A Land Of Ceaseless Conflict
Sovereign Wealth Funds Forestall Real-Estate Investments As COVID-19 Pandemic Bites
Real estate – The return of the living dead; well, for now
Eliminating COVID-19: What the world can learn from NZ and Taiwan
Free school meals: the lifelong impact of childhood food poverty
A year after Essex lorry deaths, UK-funded ads won't stop Vietnamese migrants risking their lives
Coronavirus stimulus checks: Bernie Sanders Wants A Yuge Bill
The Bill From MMT: Higher Taxes, More Austerity, Rising Inflation Or Eventual Default
Coronavirus stimulus checks: Pelosi on negotiations, we’re ‘just about there’
From Black Rain To Black Swans: The Importance Of Hedging
Coronavirus stimulus checks: 2 GOP Senators open to vote on bigger stimulus
US Manufacturing Disappoints In Early October PMI Data As Election Anxiety Builds
Business Round Table Must Help Ensure Free And Fair Elections
World Reports Record Jump In COVID-19 Cases As Outbreak Explodes Across Europe, Midwest: Live Updates
Global Markets Rise Despite Fading Odds Of Stimulus Deal
Emerging and Frontier Markets: Policy Tools in Times of Financial Stress
Blood of recovered Covid-19 patients shows little benefit as treatment
FDA Approves Gilead's Remdesivir To Treat COVID-19 Despite Data Showing Drug Doesn't Work
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Do we have to toss Halloween out the window this year, too? Public health experts give some guidelines
How to use COVID-19 testing and quarantining to safely travel for the holidays
In two political battlegrounds, thousands of mail-in ballots are on the verge of being rejected
USD/CAD drifting ahead of US PMIs
Will The US Avoid Eurozone’s Rising Double-Dip Recession Risk?
Gilead’s remdesivir finally gets US approval